Oral a adrenoceptor blockade as a treatment of erectile dysfunction

World Journal of Urology

Volumn 19, Issue 1, 2001, Pages 9-13

  Andersson, Karl Erik ^a   Stief, Christian ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; NORADRENALIN;

HUMAN; IMPOTENCE; MALE; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; REVIEW;

ADMINISTRATION, ORAL; ADRENERGIC ALPHA-ANTAGONISTS; HUMANS; IMPOTENCE; MALE; NOREPINEPHRINE; RECEPTORS, ADRENERGIC, ALPHA;

EID: 0035261491     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007093     Document Type: Article

References (46)

1. Andersson K-E, Wagner G (1995) Physiology of penile erection. Physiol Rev 75: 191-236
2. Andersson K-E, Hedlund P, Alm P (2000) Sympathetic pathways and adrenergic innervation of the penis. Int J Impôt Res 12: 1-8
3. Baumgart D, Haude M, Gorge G, Liu F, Ge J, GrosseEggebrecht C, Erbel R, Heusch G (1999) Augmented alphaadrenergic constriction of atherosclerotic human coronary arteries. Circulation 99: 2090-2097
4. Becker AJ, Stief CG, Machtens S, Schultheiss D, Hartmann U, Truss MC, Jonas U (1998) Oral phentolamine as treatment for erectile dysfunction. J Urol 159: 1214-1216
5. Brindley GS (1986) Pilot experiments on the actions of drugs injected into the human corpus cavernosum penis. Br J Pharmacol 87: 495-500
6. Charney DS, Heninger GR, Redmond DE Jr (1983) Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine. Life Sei 33: 19-29
7. Charney DS, Heninger GR, Sternberg DE (1982) Assessment of alpha 2 adrenergic autoreceptor function in humans: effects of oral yohimbine. Life Sei 30: 2033-2041
8. Daniels DV, Gever JR, Jasper JR, Kava MS, Lesnick JD, Meloy TD, Stepan G, Williams TJ, Clarke DE, Chang DJ, Ford AP (1999) Human cloned alpha lA-adrenoceptor isoforms display alpha 1 L-adrenoceptor pharmacology in functional studies. Eur J Pharmacol 370: 337-343
9. Danjou P, Alexandre L, Warot D, Lacomblez L, Puech AJ (1988) Assessment of erectogenic properties of apomorphine and yohimbine in man. Br J Clin Pharmacol 26: 733-739
10. Davis B, Chappie. C, Chess-Williams R (1999) The alLadrenoceptor mediates contraction in human erectile tissue. Eur J Urol 35 [Suppl 2]: 102 (abstract 406)
11. Ernst E, Pittler MH (1998) Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol 159: 433 436
12. Goepel M, Krege S, Price DT, Michelotti GA. Schwinn DA, Michel MC (1999) Characterization of alpha-adrenoceptor subtypes in the corpus cavernosum of patients undergoing sex change. J Urol 162: 1793-1799
13. Goldberg MR, Robertson D (1983) Yohimbine: a pharmacological probe for study of the alpha 2-adrenoreceptor. Pharmacol Rev 35: I43-180
14. Goldstein I (2000) Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction. Int J Impôt Res 12 [Suppl 1]: S75-80
15. Gould LA, Reddy CV (1979) Oral therapy with phentolamine in chronic congestive heart failure. Chest 75: 487491
16. Grimm RH, Grandits GA, Prineas RJ, McDonald RH, Lewis CE, Flack JM, Yunis C, Svendsen K, Liebson PR, Elmer PJ, Stamler J (1997) Long-term effects on sexual functions of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of mild hypertension study (TOMHS). Hypertension 29: 8-14
17. Gupta S, Moreland RB, Yang S, Gallant CM, Goldstein I, Traish A (1998) The expression of functional postsynaptic alpha2-adrenoceptors in the corpus cavernosum smooth muscle. Br J Pharmacol 123: 1237-1245
18. Gwinup G (1988) Oral phentolamine in non-specific erectile insufficency. Ann Intern Med 109: 162
19. Hattori Y, Kanno M (1998) Role of alpha 1-adrenoceptor subtypes in production of the positive inotropic effects in mammalian myocardium: implications for the alpha 1-adrenoceptor subtype distribution. Life Sei 62: 1449-1453
20. Hoffman BB, Lefkowitz RJ (1996) Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Harman JG, Limbird LE, Molinoff PB, Ruddon RW, Oilman AG (eds) Goodman and Gilmans the pharmacological basis of therapeutics, 9th edn. McGraw-Hill, New York, pp 199-248
21. Hussain MB, Marshall I (1997) Characterization of alpha 1adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery. Br J Pharmacol 122: 849-858
22. Kaplan SA, Reis RB, Kohn IJ, Shabsigh R, Te AE (1998) Combination therapy using oral a-blockers and intracavernosal injection in men with erectile dysfunction. Urology 52: 739-743
23. Kohno Y, Saito H, Takita M, Kigoshi S, Muramatsu I (1994) Heterogeneity of aradrenoceptor subtypes involved in adrenergic contractions of dog blood vessels. Br J Pharmacol 112: 1167-1173
24. Kunelius P, Hakkinen J, Lukkarinen O (1997) Is high-dose yohimbine hydrochloride effective in the treatment of mixedtype impotence? A prospective, randomized, controlled doubleblind crossover study. Urology 49: 441-444
25. Levin RM, Wein AJ (1980) Adrenergic alpha receptors outnumber beta receptors in human penile corpus cavernosum. Invest Urol 18: 225-226
26. Montorsi F, Strambi LF, Guazzoni G, Galli L, Barbieri L, Rigatti P, Pizzini G, Miani A (1994) Effect of yohimbinetrazodone on psychogenic impotence: a randomized, doubleblind, placebo-controlled study. Urology 44: 732-736
27. Morales A, Condra M, Owen JA, Surridge DH, Fenemore J, Harris C (1987) Is yohimbine effective in the treatment of organic impotence? Results of a controlled trial. J Urol 137: 1168-1172
28. Price LH, Charney DS, Heninger GR (1984) Three cases of manic symptoms following yohimbine administration. Am J Psychiatry 141: 1267-1268
29. Price DT, Schwinn DA, Kim JH, Carson III CC, Caron MG, Lefkowitz RJ (1993) Alpha, adrenergic receptor subtype mRNA expression in human corpus cavernosum. J Urol 149: 285A (abstract 287)
30. Reid K, Surridge DH, Morales A, Condra M, Harris C, Owen J, Fenemore J (1987) Double-blind trial of yohimbine in treatment of psychogenic impotence. Lancet 2: 421-423
31. Riley AJ, Goodman RE, Kellett JM, Orr R (1989) Double blind trial of yohimbine hydrochloride in the treatment of erection inadequacy. Sex Marital Ther 4: 17-26
32. Rudner XL, Berkowitz DE, Booth JV, Funk BL, Cozart KL, D'Amico EB, El-Moalem H, Page SO, Richardson CD, Winters B. Marucci L, Schwinn DA (1999) Subtype specific regulation of human vascular alpha(l)-adrenergic receptors by vessel bed and age. Circulation 100: 2336-2343
33. Schreiber R, Maier PT, Gunnar RM, Loeb HS (1979) Memodynamic improvement following single dose of oral phentolamine. Administration in patients with chronic low output cardiac failure. Chest 76: 571-575
34. Schwinn DA. Michelotti GA (2000) alpha 1-Adrenergic receptors in the lower urinary tract and vascular bed: potential role for the alpha Id subtype in filling symptoms and effects of ageing on vascular expression. Br J Urol 85 [Suppl] 2: 6 11
35. Simonsen U, Prieto D, Hernandez M, Saenz de Tejada I, Garcia-Sacristan A (1997) Prejunctional alpha 2-adrenoceptors inhibit nitrergic neurotransmission in horse penile resistance arteries. J Urol 157: 2356-2360
36. Sironi G, Colombo D, Poggesi E, Leonardi A, Testa R, Rampin O. Bernabe J, Giuliano F (2000) Effects of intracavernous administration of selective antagonists of alpha(l)adrenoceptor subtypes on erection in anesthetized rats and dogs. J Pharmacol Exp Ther 292: 974-981
37. Susset JG, Tessier CD, Wincze J, Bansal S, Malhotra C, Schwacha MG (1989) Effect of yohimbine hydrochloride on erectile impotence: a double-blind study. J Urol 141: 1360-1363
38. long YC, Cheng JT (1997) Subtyping of alpha 1-adrenoceptors responsible for the contractile response in the rat corpus cavernosum. Neurosci Lett 228: 159-162
39. Traish A. Gupta S, Gallant C, Huang YH, Goldstein I (1998) Phentolamine mesylate relaxes penile corpus cavernosum tissue by adrenergic and non-adrenergic mechanisms. Int J Impôt Res 10: 215-223
40. Traish A, Kirn NN, Moreland RB, Goldstein I (2000) Role of alpha adrenergic receptors in erectile function. Int J Impôt Res 12 [Suppl I]: S48-63
41. Traish AM, Netsuwan N, Daley J, Padman-Nathan H, Goldstein I, Saenz de Tejada I (1995) A heterogeneous population of 1 adrenergic receptors mediates contraction of human corpus cavernosum smooth muscle to norepinephrine. J Urol 153: 222-227
42. Vargas HM, Gorman AJ (1995) Vascular alpha-1 adrenergic receptor subtypes in the regulation of arterial pressure. Life Sei 57: 2291-2308
43. Varma DR, Deng X-F (2000) Cardiovascular al-adrenoceptor subtypes: functions and signaling. Can J Physiol Pharmacol. 78: 267-292
44. Villalobos-Molina R, Ibarra M (1999) Vascular alrj-adrenoceptors: are they related to hypertension? Arch Med Res 30: 347-352
45. Vogt HJ, Brandi P, Kockott G, Schmilz JR, Wiegand MH, Schadrack J, Gierend M (1997) Double-blind, placebo-controlled safety and efficacy trial with yohimbine hydrochloride in the treatment of nonorganic erectile dysfunction. Int J Impôt Res 9: 155-161
46. Zorgniotti AW (1994) Experience with buccal phentolamine mesylate for impotence. Int J Impôt Res 6: 37-41